BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37603520)

  • 1. Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma.
    Xie H; Qin C; Zhou X; Liu J; Yang K; Nong J; Luo J; Peng T
    Medicine (Baltimore); 2023 Aug; 102(33):e34765. PubMed ID: 37603520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment.
    Nurzat Y; Su W; Min P; Li K; Xu H; Zhang Y
    Front Oncol; 2021; 11():751875. PubMed ID: 34660316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
    Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
    J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes.
    Xiong C; Wang G; Bai D
    Bioengineered; 2020 Dec; 11(1):1034-1046. PubMed ID: 32951492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of ITGA and ITGB superfamily members in patients with high grade serous ovarian cancer.
    Zhu T; Chen R; Wang J; Yue H; Lu X; Li J
    Cancer Cell Int; 2020; 20():257. PubMed ID: 32565741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coiled-Coil Domain-Containing Protein 45 Is a Potential Prognostic Biomarker and Is Associated with Immune Cell Enrichment of Hepatocellular Carcinoma.
    Liu S; Jia L; Quan B; Rong G; Li M; Xie R; Cai Y; Bi Y; Han S
    Dis Markers; 2022; 2022():7745315. PubMed ID: 36618966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.
    Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB
    Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma.
    Wang H; Xu F; Yang F; Lv L; Jiang Y
    Sci Rep; 2021 Jul; 11(1):14611. PubMed ID: 34272452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes.
    Liu R; Wang G; Zhang C; Bai D
    World J Surg Oncol; 2021 Mar; 19(1):70. PubMed ID: 33712023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
    Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
    Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
    Front Oncol; 2021; 11():713017. PubMed ID: 34595113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic and immune infiltration role of ITGB superfamily members in non-small cell lung cancer.
    Wu J; Wang W; Li Z; Ye X
    Am J Transl Res; 2022; 14(9):6445-6466. PubMed ID: 36247270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
    Tang Y; Zhang Y; Hu X
    Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a prognostic risk assessment model for lung adenocarcinoma based on Integrin β family-related genes.
    Wu Y; Fu L; Wang B; Li Z; Wei D; Wang H; Zhang C; Ma Z; Zhu T; Yu G
    J Clin Lab Anal; 2022 Jun; 36(6):e24419. PubMed ID: 35403268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CFHR4 as a Potential Prognosis Biomarker Associated With lmmune Infiltrates in Hepatocellular Carcinoma.
    Yu H; Wang C; Ke S; Bai M; Xu Y; Lu S; Feng Z; Qian B; Xu Y; Zhou M; Li Z; Yin B; Li X; Hua Y; Zhou Y; Pan S; Fu Y; Ma Y
    Front Immunol; 2022; 13():892750. PubMed ID: 35812416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.